<div id="readability-page-1"><ul><li>Snowflake Stock Is on Fire—It’s Still Not Too Late to Buy</li></ul><p>UnitedHealth Group Incorporated (NYSE:UNH - Free Report) - Equities research analysts at Zacks Research raised their Q2 2026 earnings per share (EPS) estimates for UnitedHealth Group in a research note issued to investors on Tuesday, November 11th. Zacks Research analyst Team now expects that the healthcare conglomerate will post earnings of $4.36 per share for the quarter, up from their previous forecast of $4.32. Zacks Research currently has a &#34;Hold&#34; rating on the stock. The consensus estimate for UnitedHealth Group's current full-year earnings is $29.54 per share. Zacks Research also issued estimates for UnitedHealth Group's Q2 2027 earnings at $4.90 EPS.</p><div><p><span></span><span>Get <strong>UnitedHealth Group</strong> alerts:</span></p></div><p>UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating analysts' consensus estimates of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business had revenue of $113.16 billion during the quarter, compared to analyst estimates of $113.19 billion. During the same period in the prior year, the firm posted $7.15 EPS. UnitedHealth Group's quarterly revenue was up 12.2% compared to the same quarter last year. </p><ul><li>UnitedHealth Group’s Recovery in Full Swing: Buy While It's Down</li></ul><p>A number of other research analysts also recently issued reports on the company. UBS Group upped their price objective on UnitedHealth Group from $378.00 to $430.00 and gave the company a &#34;buy&#34; rating in a research note on Wednesday, October 29th. Morgan Stanley increased their price target on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an &#34;overweight&#34; rating in a research report on Friday, September 12th. Leerink Partners  set a $410.00 target price on shares of UnitedHealth Group and gave the company an &#34;outperform&#34; rating in a research note on Wednesday, October 29th. Bank of America lifted their price target on shares of UnitedHealth Group from $350.00 to $390.00 and gave the stock a &#34;neutral&#34; rating in a report on Wednesday, October 8th. Finally, Baird R W downgraded UnitedHealth Group from a &#34;hold&#34; rating to a &#34;strong sell&#34; rating in a research report on Thursday, July 31st. Eighteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued  a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of &#34;Moderate Buy&#34; and an average target price of $397.12.</p><p><b>Check Out Our Latest Stock Analysis on UnitedHealth Group</b></p><h2>UnitedHealth Group Price Performance</h2><ul><li>Big Banks Are Setting the Tone as Earnings Season Kicks Off</li></ul><p>Shares of NYSE UNH opened at $326.95 on Wednesday. The company has a quick ratio of 0.85, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. The company has a market capitalization of $296.16 billion, a PE ratio of 17.06, a PEG ratio of 2.28 and a beta of 0.47. The stock's 50 day moving average price is $346.44 and its 200-day moving average price is $320.53. UnitedHealth Group has a twelve month low of $234.60 and a twelve month high of $624.48. </p><h2>UnitedHealth Group Announces Dividend</h2><p>The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be issued a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group's dividend payout ratio (DPR) is presently 46.14%. </p><h2>Hedge Funds Weigh In On UnitedHealth Group</h2><p>Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Caitlin John LLC increased its stake in shares of  UnitedHealth Group by 14.8% in the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate's stock worth $451,000 after acquiring an additional 111 shares in the last quarter.  Murphy Pohlad Asset Management LLC raised its position in  UnitedHealth Group by 21.8% in the 2nd quarter. Murphy Pohlad Asset Management LLC now owns 4,425 shares of the healthcare conglomerate's stock worth $1,380,000 after buying an additional 791 shares during the last quarter.  Triumph Capital Management bought a new stake in  UnitedHealth Group in the 2nd quarter worth approximately $1,324,000.  Wealth Effects LLC lifted its holdings in  UnitedHealth Group by 14.4% in the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate's stock valued at $1,463,000 after acquiring an additional 591 shares during the period.  Finally, Towercrest Capital Management bought a new position in  UnitedHealth Group in the second quarter worth approximately $236,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors. </p><h2>UnitedHealth Group Company Profile</h2> (Get Free Report)<p>UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than UnitedHealth Group</li><li>The Risks of Owning Bonds</li><li>Occidental Petroleum is a Buy in Q4 2025</li><li>Stock Market Upgrades: What Are They?</li><li>3 Beaten-Down Stocks With Rebound Potential This Earnings Season</li><li>Why Understanding Call Option Volume is Essential to Successful Options Trading</li><li>Amazon Is One of the Clearest Buys If the Market Dips Again</li></ul> <p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in UnitedHealth Group Right Now?</h2><p>Before you consider UnitedHealth Group, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.</p><p>While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>UnitedHealth Group Incorporated (NYSE:UNH - Free Report) - Equities research analysts at Zacks Research raised their Q2 2026 earnings per share (EPS) estimates for UnitedHealth Group in a research note issued to investors on Tuesday, November 11th.</p>

Q2 EPS Forecast for UnitedHealth Group Raised by Analyst